Seroquel Related Published Studies
Well-designed clinical trials related to Seroquel (Quetiapine)
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. [2009.08.20]
A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. [2009.08]
Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients. [2009.07]
Olanzapine compared to quetiapine in adolescents with a first psychotic episode. [2009.07]
Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study. [2009.06]
Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia. [2009.06]
Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. [2009.04]
Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study. [2009.04]
A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. [2009.04]
Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). [2009.04]
Effect of quetiapine vs. placebo on response to two virtual public speaking exposures in individuals with social phobia. [2009.04]
Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects. [2009.03]
A randomized controlled trial of quetiapine for psychosis in Parkinson's disease. [2009]
Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep. [2008.12]
Dosing quetiapine in drug-naive first-episode psychosis: A controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years. [2008.11.18]
Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years. [2008.11]
Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study. [2008.10]
Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. [2008.10]
A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. [2008.09]
Bioequivalence study of a generic quetiapine in healthy male volunteers. [2008.09]
Quetiapine for the treatment of bipolar mania in older adults. [2008.09]
The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: a preliminary trial. [2008.08.28]
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). [2008.08]
Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial. [2008.05.30]
A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. [2008.05]
Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies. [2008.05]
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. [2008.05]
Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder. [2008.04]
Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study. [2008.04]
Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia. [2008.03]
Modulation of human motor cortex excitability by quetiapine. [2008.03]
A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Outpatients With Bipolar Disorder and Alcohol Use Disorders. [2008.02.27]
Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. [2008.02.15]
Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. [2008.02]
Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study. [2008.01]
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial. [2008.01]
Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies. [2008]
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?-A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting. [2007.12]
[Administration of once-daily extended release quetiapine in schizophrenic disorders] [2007.12]
Cognition, functioning and quality of life in schizophrenia treatment: Results of a one-year randomized controlled trial of olanzapine and quetiapine. [2007.11]
Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder. [2007.11]
Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study. [2007.10.01]
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia. [2007.10]
Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study. [2007.09.18]
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms. [2007.09]
Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function. [2007.09]
A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. [2007.08]
Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study. [2007.08]
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. [2007.07]
Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. [2007.07]
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. [2007.07]
Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study. [2007.07]
Validated HPLC-MS/MS method for determination of quetiapine in human plasma. [2007.06.28]
Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study. [2007.06]
A preclinical and clinical rationale for quetiapine in mood syndromes. [2007.06]
Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. [2007.06]
Quetiapine for acute mania in bipolar disorder. [2007.05.15]
A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder. [2007.05]
Quetiapine for agitation or psychosis in patients with dementia and parkinsonism. [2007.04.24]
Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial. [2007.03]
Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. [2007.03]
Effects of quetiapine on cognitive functioning in obsessive-compulsive disorder. [2007.03]
Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration. [2007.02.15]
Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study. [2007.02]
A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life. [2007.01]
Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study. [2007.01]
Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study. [2007]
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). [2006.12]
Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. [2006.11]
Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine. [2006.10]
Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial. [2006.09]
Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study. [2006.07]
Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia. [2006.06]
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. [2006.04]
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. [2006.04]
A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. [2006.04]
Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study. [2006.03]
A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. [2006.03]
The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects. [2006.03]
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. [2005.12]
Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. [2005.10]
Rapid dose escalation with quetiapine: a pilot study. [2005.08]
Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease. [2005.08]
Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia. [2005.07]
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. [2005.07]
Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study. [2005.07]
Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. [2005.06]
The effect of quetiapine on aggression and hostility in patients with schizophrenia. [2005.06]
Effects of quetiapine and haloperidol on body mass index and glycaemic control: a long-term, randomized, controlled trial. [2005.06]
Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder. [2005.05]
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. [2005.04.16]
Neuroendocrine effects of quetiapine in healthy volunteers. [2005.03]
A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. [2005.01]
Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. [2005.01]
Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. [2004.12]
Quetiapine in bipolar disorder: Increasing evidence of efficacy and tolerability. [2004.10]
A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone. [2004.09]
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. [2004.08]
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. [2004.07]
Quetiapine in schizophrenia: onset of action within the first week of treatment. [2004.07]
Sleep-promoting properties of quetiapine in healthy subjects. [2004.07]
|
